Relative Strength Chart Scholar Rock Holding Corporation
Stocks
SRRK
US80706P1030
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-11-11 EST
|
5-day change | 1st Jan Change | ||
| 46.60 USD | -2.92% |
|
+5.96% | +5.79% |
| 11-10 | Scholar Rock Holding Corporation, Q3 2026 Earnings Call, Nov 10, 2026 | |
| 11-10 | Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Tuesday Amid October Consumer Inflation Report | MT |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Bio Therapeutic Drugs | -2.92% | +5.96% | +5.79% | +58.67% | +40.87% | 5.85B |  |  | |
- Stock Market
- Stocks
- SRRK Stock
- Charts Scholar Rock Holding Corporation
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
